MetaTrader
  • Markets
  • Charts & Ideas
  • Algo
  • News
  • Store
  • Brokers
  • Download
  • Economic Calendar
  • Trading Signals
  • WebTerminal
  • Heatmap
  • Русский
  • 中文
  • Español
  • Português
  • 日本語
  • Deutsch
  • 한국어
  • Français
  • Italiano
  • Türkçe
Estrella Immunopharma, Inc. Common Stock

ESLA

#3920
Estrella Immunopharma, Inc. - Common Stock
1.0 9 USD
-3.54%
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
1.09
1.09
Year Range
0.78
3.15
Daily Change
-3.54%
Monthly Change
-28.29%
6 month change
-50.45%
Year Change
+11.22%
Previous Close
1.1 3
Open
1.0 9
Low
1.0 9
High
1.0 9
Volume
2
  1. Markets
  2. US Stock Market
  3. Healthcare
  4. ESLA
Open full chart Full chart

Financials

Overview Statement Statistics
Quarterly Annual
  • Market Capitalization 46.91 M
  • Employee N/A
  • Founded 2006
  • CEO N/A
  • Website www.estrellabio.com
  • Headquarter California, United States
  • FIGI BBG00ZDR7G05
  • Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents

News

Investing Investing
ESLA
2026.02.09
Estrella reports 100% complete response rate in lymphoma trial
Investing Investing
ESLA
2026.02.03
Estrella to present phase 1 data on CD19-targeted cell therapy
Investing Investing
ESLA
2026.01.13
Estrella Immunopharma receives Nasdaq notice for delayed annual meeting
Investing Investing
ESLA
2026.01.06
Estrella Immunopharma closes $8 million registered direct offering
Investing Investing
ESLA
2026.01.05
Estrella Immunopharma stock falls after announcing $8 million offering
Investing Investing
ESLA
2026.01.05
Estrella Immunopharma raises $8 million through registered offering
Investing Investing
ESLA
2025.12.04
Estrella Immunopharma stock rises as cancer therapy advances to Phase II
Investing Investing
ESLA
2025.12.04
Estrella’s EB103 advances to Phase II after positive safety data
Investing Investing
ESLA
2025.11.03
Estrella Immunopharma stock soars after 100% complete response rate in trial
Investing Investing
ESLA
2025.11.03
Estrella’s lymphoma therapy shows 100% response rate in phase I trial
Investing Investing
ESLA
2025.10.06
Estrella Immunopharma regains Nasdaq compliance after capital raise
Investing Investing
ESLA
2025.09.29
Estrella Immunopharma regains Nasdaq compliance on bid price and market value

Markets

  • US Stock Market
  • Currencies
  • Cryptocurrencies
  • Metals
  • Commodities

Charts & Ideas

  • Trading Ideas
  • Education Ideas
  • Charts

MQL5 Community

  • Store
  • Signals
  • Forum
  • Articles
  • CodeBase

News

  • US Stock Market
  • Currencies
  • Cryptocurrencies
  • Metals
  • Commodities

Brokers

  • All Brokers
  • Forex
  • Stock
  • Metals
MetaTrader 5
Scan to install from App Store Scan to install from Google Play Scan to install from Huawei AppGallery Scan to install APK
MQL5 Channels
Scan to install from App Store Scan to install from Google Play Scan to install from Huawei AppGallery Scan to install APK
Economic Calendar
Scan to install from App Store Scan to install from Google Play Scan to install from Huawei AppGallery Scan to install APK
Risk Disclosure Terms of Use Help Contacts and Requests Legal
Copyright 2000-2026, MetaQuotes Ltd